Autism Biomarkers Consortium for Clinical Trials

Location: New Haven, CT - Yale University
Start Date: July 1st, 2015
End Date: June 30th, 2019

The Autism Biomarkers Consortium for Clinical Trials (ABC-CT) is a multicenter research study based at Yale that spans Duke University, Boston Children’s Hospital, the University of Washington/Seattle Children’s Research Institute and the University of California, Los Angeles. The aim of the consortium is to develop reliable and objective measurements of social function and communication in people with autism.

Researchers at the McPartland lab have clinical studies available that examine your child’s social, communication, and emotional skills. This research will lead to new methods to develop, track, and assess treatments in ASD. You will receive a psychoeducational evaluation describing your child’s development over six months.

Eligibility

We are currently recruiting both typically developing children and children with a diagnosis of ASD between the ages of 6 and 11 years old.

Contact Information

To learn more about the study or to participate, please call us at 203-737-4586 or email our team at asdbiomarkers@yale.edu.